The efficacy of self‐monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release–based regimen. A multicentre, randomized, parallel‐group, 6‐month evaluation (DINAMIC 1 study)

Abstract

In patients with type 2 diabetes, the application of SMBG as an adjunct to oral antidiabetic agent therapy results in further reductions in HbA1c.